Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stacey Ricci

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Oncologist|April 15, 2006
Chemotherapeutic approaches for targeting cell death pathwaysM Stacey Ricci, Wei-Xing Zong
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2003
DNA footprintingM Stacey Ricci, Wafik S El-Deiry
Blood|May 12, 2026
Biosimilars approved for hematologists: lessons from comparative efficacy studies and comparative analytical assessmentsThomas Herndon, Nina N Brahme, M Stacey Ricci
Cancer Research|April 3, 2008
Mcl-1: a gateway to TRAIL sensitizationSeok-Hyun Kim, M Stacey Ricci, Wafik S El-Deiry
JAMA|March 9, 2026
FDA's Regulatory Reforms to Unlock Competition and Lower Drug Costs: Breaking the Biosimilar BottleneckMartin A Makary, Sarah Yim, Mustafa Ünlü, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2016
FDA's Approach to Regulating BiosimilarsSteven J Lemery, M Stacey Ricci, Patricia Keegan, et al.
Plos One|July 27, 2011
Dysregulated ΔNp63α inhibits expression of Ink4a/arf, blocks senescence, and promotes malignant conversion of keratinocytesLinan Ha, Roshini M Ponnamperuma, Steven Jay, et al.
Toxicology and Applied Pharmacology|January 5, 2010
Regulatory aspects of oncology drug safety evaluation: past practice, current issues, and the challenge of new drugsHans Rosenfeldt, Timothy Kropp, Kimberly Benson, et al.
Cancer Biology & Therapy|September 21, 2007
Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4Robyn T Sussman, M Stacey Ricci, Lori S Hart, et al.
Cancer Biology & Therapy|November 19, 2005
Modulation of TRAIL-induced tumor cell apoptosis in a hypoxic environmentPatrick A Mayes, Latoya Campbell, M Stacey Ricci, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Oncologist|April 15, 2006
Chemotherapeutic approaches for targeting cell death pathwaysM Stacey Ricci, Wei-Xing Zong
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2003
DNA footprintingM Stacey Ricci, Wafik S El-Deiry
Blood|May 12, 2026
Biosimilars approved for hematologists: lessons from comparative efficacy studies and comparative analytical assessmentsThomas Herndon, Nina N Brahme, M Stacey Ricci
Cancer Research|April 3, 2008
Mcl-1: a gateway to TRAIL sensitizationSeok-Hyun Kim, M Stacey Ricci, Wafik S El-Deiry
JAMA|March 9, 2026
FDA's Regulatory Reforms to Unlock Competition and Lower Drug Costs: Breaking the Biosimilar BottleneckMartin A Makary, Sarah Yim, Mustafa Ünlü, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2016
FDA's Approach to Regulating BiosimilarsSteven J Lemery, M Stacey Ricci, Patricia Keegan, et al.
Plos One|July 27, 2011
Dysregulated ΔNp63α inhibits expression of Ink4a/arf, blocks senescence, and promotes malignant conversion of keratinocytesLinan Ha, Roshini M Ponnamperuma, Steven Jay, et al.
Toxicology and Applied Pharmacology|January 5, 2010
Regulatory aspects of oncology drug safety evaluation: past practice, current issues, and the challenge of new drugsHans Rosenfeldt, Timothy Kropp, Kimberly Benson, et al.
Cancer Biology & Therapy|September 21, 2007
Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4Robyn T Sussman, M Stacey Ricci, Lori S Hart, et al.
Cancer Biology & Therapy|November 19, 2005
Modulation of TRAIL-induced tumor cell apoptosis in a hypoxic environmentPatrick A Mayes, Latoya Campbell, M Stacey Ricci, et al.
Pageof 2